These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7976233)

  • 61. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
    Stensrud P; Sjaastad O
    Ups J Med Sci Suppl; 1980; 31():37-40. PubMed ID: 7006182
    [TBL] [Abstract][Full Text] [Related]  

  • 62. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
    Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine.
    Sørensen PS; Hansen K; Olesen J
    Cephalalgia; 1986 Mar; 6(1):7-14. PubMed ID: 3516409
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis.
    Micieli G; Cavallini A; Marcheselli S; Mailland F; Ambrosoli L; Nappi G
    Int J Clin Pharmacol Ther; 2001 Apr; 39(4):144-51. PubMed ID: 11332869
    [TBL] [Abstract][Full Text] [Related]  

  • 65. N alpha methyl histamine versus propranolol in migraine prophylaxis.
    Millán-Guerrero RO; Isais-Millán R; Guzmán-Chávez B; Castillo-Varela G
    Can J Neurol Sci; 2014 Mar; 41(2):233-8. PubMed ID: 24534036
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
    Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
    Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
    [TBL] [Abstract][Full Text] [Related]  

  • 67. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tolfenamic acid and migraine--aspects on prostaglandins and leukotrienes.
    Vapaatalo H
    Pharmacol Toxicol; 1994; 75 Suppl 2():76-80. PubMed ID: 7816789
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
    Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F
    Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of beta-blockers in migraine. A critical review.
    Tfelt-Hansen P
    Cephalalgia; 1986; 6 Suppl 5():15-24. PubMed ID: 2879629
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study.
    Schrader H; Stovner LJ; Helde G; Sand T; Bovim G
    BMJ; 2001 Jan; 322(7277):19-22. PubMed ID: 11141144
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tolfenamic acid and ergotamine abuse.
    Ala-Hurula V; Myllylä VV; Hokkanen E; Tokola O
    Headache; 1981 Nov; 21(6):240-2. PubMed ID: 7309503
    [No Abstract]   [Full Text] [Related]  

  • 73. Sodium Valproate versus Propranolol in paediatric migraine prophylaxis.
    Ashrafi MR; Shabanian R; Zamani GR; Mahfelati F
    Eur J Paediatr Neurol; 2005; 9(5):333-8. PubMed ID: 16120482
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study.
    van de Ven LL; Franke CL; Koehler PJ
    Cephalalgia; 1997 Aug; 17(5):596-9. PubMed ID: 9251876
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Use of propranolol in the treatment of migraine].
    Klimek A; Nevodnichiĭ A
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):75-8. PubMed ID: 7064609
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drugs for preventing migraine headaches in children.
    Victor S; Ryan SW
    Cochrane Database Syst Rev; 2003; (4):CD002761. PubMed ID: 14583952
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative study of nadolol and propranolol in prophylactic treatment of migraine.
    Ryan RE
    Am Heart J; 1984 Oct; 108(4 Pt 2):1156-9. PubMed ID: 6148878
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tolfenamic acid in combination with caffeine: absorption during acute migraine.
    Tokola RA
    Methods Find Exp Clin Pharmacol; 1985 Oct; 7(10):545-50. PubMed ID: 3878441
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.